Hydroxyprogesteroneacetate CAS:302-23-8

A na-eji Hydroxyprogesteroneacetate eme ihe n'ọnọdụ dị iche iche n'ihi ihe ndị na-akpata progestogenic na mmetụta ọgwụ. Na ọmụmụ nwa na ụmụ nwanyị, a na-enye ya ọgwụ iji gbochie ọmụmụ nwa tupu oge eruo n'ime ụmụ nwanyị ndị nwere ihe ize ndụ nke ịmụ nwa tupu oge eruo. Site n'ịmetụta gburugburu ebe obibi akpanwa na usoro ntozu nke cervical, Hydroxyprogesteroneacetate na-enyere aka belata ohere nke ịmụ nwa n'oge ma melite nsonaazụ ụmụ amụrụ ọhụrụ. Ọzọkwa, na ọgwụgwọ nnọchi homonụ (HRT), a na-enye Hydroxyprogesteroneacetate iji belata mgbaàmà nke ịhụ nsọ ma ọ bụ ime ka ọkwa homonụ dị mma. Ọ na-eṅomi ihe omume nke progesterone eke, na-akwado ahụike endometrial ma na-egbochi uto akpanwa na-adịghị mma. Ọgwụgwọ homonụ a dị mkpa maka ijikwa ọnọdụ dịka mgbaàmà vasomotor nke menopausal, osteoporosis postmenopausal, na nchekwa endometrial na ọgwụgwọ estrogen. Ọzọkwa, a na-eji Hydroxyprogesteroneacetate agwọ ụfọdụ nsogbu gynecological, dị ka ọbara ọgbụgba akpanwa na-adịghị mma, amenorrhea, na polycystic ovary syndrome (PCOS). Ike ya ịhazi usoro ịhụ nsọ ma kwalite ịmụ nwa mgbe niile na-eme ka ọ baa uru n'ịgwọ nsogbu ahụike ọmụmụ na nchegbu ọmụmụ. Ọzọkwa, enwere ike iji Hydroxyprogesteroneacetate na ọgwụ ndị ọzọ maka ebumnuche mgbochi afọ ime ma ọ bụ na ọrịa kansa ndị nwere mmetụta na homonụ iji gbanwee ọrụ nnabata homonụ. N'ozuzu, ojiji dị iche iche nke Hydroxyprogesteroneacetate na ahụike ụmụ nwanyị, ọgwụ ọmụmụ, na nsogbu endocrine na-egosipụta mkpa ọ dị dị ka ọgwụ bara uru nke nwere ọtụtụ ojiji ọgwụgwọ. Ọrụ ya n'ịnọgide na-enwe nguzozi homonụ, ịkwado afọ ime, na ijikwa ọnọdụ ụmụ nwanyị na-emesi mkpa ọ dị na omume nlekọta ahụike nke oge a ike.